Neurostimulators are sophisticated therapeutic systems, which are designed to generate and stimulate neuronal circuitries or tissues for rehabilitatory purposes. The present versions of neurostimulators are seeking to incorporate a sensor to sense the desired neural or physiological parameter. This sensor would then iteratively modify the stimulatory signal to other variations for accurate and more dynamically adapted therapeutic stimulation.
New research from Frost & Sullivan (http://www.ti.frost.com), Advancements in Neurostimulators, finds that the number of people requiring neurotherapeutic attention has been increasing globally, primarily due to growing stress and strain of the present day lifestyle. With challenging work pressure and increased competition, more people are succumbing to lifestyle diseases and hence, there is an accretion in patients who need neuro-rehabilitative treatment.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the Advancements in Neurostimulators, then send an e-mail to Melina Trevino - Corporate Communications at email@example.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via e-mail upon receipt of the above information.
The neurostimulator industry has been making rapid strides for the past few years with a myriad of developments in itself and its allied fields. This has affected the material, design, control, and energy considerations of implantable neuroprosthetics significantly.
“Despite growing demand, one of the major challenges faced by neurostimulators is biocompatibility; no matter how it is treated or coated, an implant will always remain a foreign object to the interior physiology of the body,” says Frost & Sullivan Research Analyst Abhishek Dutta. “Therefore, issues of biocompatibility and rejection by the body are key points in the design of nerve interfaces because of the high attenuation of both nerve signals and stimulation pulses.”
Also, there is always a chance of microbial infection during the surgical insertion of an assistive or substitutive mobility aid in the body. This kind of infection may lead to failure of the implant and may further lead to other fatal health hazards.
“To counter such issues, the Food and Drug Administration (FDA) has imposed stringent regulations on all classes of medical devices which are extremely essential as they assure the consumer of product safety and efficacy,” says Dutta. “While the FDA’s control is often the singular important factor between patient safety and technological development, regulatory controls can sometimes act as the biggest hurdle that a product or technology has to overcome even after its successful construction.”
With the advent of nanotechnology the field of neurostimulators will receive a boost since many new concepts are to be introduced and implemented. This will continue to happen when the excavation through research and corresponding developments in the field of nanotechnology happen. Concepts such as self-targeting brain and neuronal implants, which can invasively attach themselves at specific locations of the nervous system, providing automated in vivo neuronal therapy, now seem to be a definite possibility.
Advancements in Neurostimulators is part of the Technical Insights Subscription, and thoroughly examines neurostimulators from a basic definitive view and probes into its variegated angles of applications. The study summarizes and analyzes the most recent developments pertaining to therapeutic and sensory organ-aiding applications using neuronal stimulation by companies and academic institutes. Interviews with the press are available.
Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.